{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:16:58Z","timestamp":1790144218348,"version":"4.0.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Influenza is a long-standing health problem. For treatment of seasonal flu and possible pandemic infections, there is a need to develop new anti-influenza drugs that have good bioavailability against a broad spectrum of influenza viruses, including the resistant strains. Relenza\u2122 (zanamivir), Tamiflu\u2122 (the phosphate salt of oseltamivir), Inavir\u2122 (laninamivir octanoate) and Rapivab\u2122 (peramivir) are four anti-influenza drugs targeting the viral neuraminidases (NAs). However, some problems of these drugs should be resolved, such as oral availability, drug resistance and the induced cytokine storm. Two possible strategies have been applied to tackle these problems by devising congeners and conjugates. In this review, congeners are the related compounds having comparable chemical structures and biological functions, whereas conjugate refers to a compound having two bioactive entities joined by a covalent bond. The rational design of NA inhibitors is based on the mechanism of the enzymatic hydrolysis of the sialic acid (Neu5Ac)-terminated glycoprotein. To improve binding affinity and lipophilicity of the existing NA inhibitors, several methods are utilized, including conversion of carboxylic acid to ester prodrug, conversion of guanidine to acylguanidine, substitution of carboxylic acid with bioisostere, and modification of glycerol side chain. Alternatively, conjugating NA inhibitors with other therapeutic entity provides a synergistic anti-influenza activity; for example, to kill the existing viruses and suppress the cytokines caused by cross-species infection.<\/jats:p>","DOI":"10.1186\/s12929-019-0567-0","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T06:55:10Z","timestamp":1571813710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Development of effective anti-influenza drugs: congeners and conjugates \u2013 a review"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiun-Jie","family":"Shie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6070-3408","authenticated-orcid":false,"given":"Jim-Min","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"14","key":"567_CR1","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1021\/jm300455c","volume":"55","author":"K Das","year":"2012","unstructured":"Das K. Antivirals targeting influenza a virus. J Med Chem. 2012;55(14):6263\u201377.","journal-title":"J Med Chem"},{"issue":"9","key":"567_CR2","doi-asserted-by":"publisher","first-page":"e108538","DOI":"10.1371\/journal.pone.0108538","volume":"9","author":"RK Syrj\u00e4nen","year":"2014","unstructured":"Syrj\u00e4nen RK, Jokinen J, Ziegler T, Sundman J, Lahdenkari M, Julkunen I, Kilpi TM. Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland. PLoS One. 2014;9(9):e108538.","journal-title":"PLoS One"},{"key":"567_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","volume":"9","author":"DS Raj\u00e3o","year":"2018","unstructured":"Raj\u00e3o DS, P\u00e9rez DR. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture. Front Microbiol. 2018;9:123.","journal-title":"Front Microbiol"},{"issue":"1","key":"567_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3201\/eid1209.05-0979","volume":"12","author":"JK Taubenberger","year":"2006","unstructured":"Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12(1):15\u201322.","journal-title":"Emerg Infect Dis"},{"issue":"5937","key":"567_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"RJ Garten","year":"2009","unstructured":"Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 a(H1N1) influenza viruses circulating in humans. Science. 2009;325(5937):197\u2013201.","journal-title":"Science."},{"issue":"10","key":"567_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.tim.2013.05.005","volume":"21","author":"JF Chan","year":"2013","unstructured":"Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013;21(10):544\u201355.","journal-title":"Trends Microbiol"},{"issue":"12 Suppl","key":"567_CR7","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/nm1141","volume":"10","author":"P Palese","year":"2004","unstructured":"Palese P. Influenza: old and new threats. Nat Med. 2004;10(12 Suppl):S82\u20137.","journal-title":"Nat Med"},{"issue":"6091","key":"567_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1126\/science.1222213","volume":"337","author":"BW Jagger","year":"2012","unstructured":"Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, et al. An overlapping protein-coding region in influenza a virus segment 3 modulates the host response. Science. 2012;337(6091):199\u2013204.","journal-title":"Science."},{"issue":"16","key":"567_CR9","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1128\/JVI.00826-09","volume":"83","author":"HM Wise","year":"2009","unstructured":"Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, Howard W, et al. A complicated message: identification of a novel PB1-related protein translated from influenza a virus segment 2 mRNA. J Virol. 2009;83(16):8021\u201331.","journal-title":"J Virol"},{"issue":"1\u20132","key":"567_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","volume":"162","author":"JH Kreijtz","year":"2011","unstructured":"Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Res. 2011;162(1\u20132):19\u201330.","journal-title":"Virus Res"},{"issue":"10","key":"567_CR11","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, et al. New world bats harbor diverse influenza a viruses. PLoS Pathog. 2013;9(10):e1003657.","journal-title":"PLoS Pathog"},{"issue":"1","key":"567_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2015.06.005","volume":"12","author":"BS Chambers","year":"2015","unstructured":"Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE. Identification of Hemagglutinin residues responsible for H3N2 antigenic drift during the 2014\u20132015 influenza season. Cell Rep. 2015;12(1):1\u20136.","journal-title":"Cell Rep"},{"issue":"4","key":"567_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7150\/thno.17071","volume":"7","author":"X Wu","year":"2017","unstructured":"Wu X, Wu X, Sun Q, Zhang C, Yang S, Li L, Jia Z. Progress of small molecular inhibitors in the development of anti-influenza virus agents. Theranostics. 2017;7(4):826\u201345.","journal-title":"Theranostics."},{"issue":"2","key":"567_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","volume":"411","author":"JS Rossman","year":"2011","unstructured":"Rossman JS, Lamb RA. Influenza virus assembly and budding. Virology. 2011;411(2):229\u201336.","journal-title":"Virology."},{"issue":"12","key":"567_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cmi.2016.07.007","volume":"22","author":"A Gaymard","year":"2016","unstructured":"Gaymard A, Le Briand N, Frobert E, Lina B, Escuret V. Functional balance between neuraminidase and haemagglutinin in influenza viruses. Clin Microbiol Infect. 2016;22(12):975\u201383.","journal-title":"Clin Microbiol Infect"},{"issue":"14","key":"567_CR16","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1021\/jm300455c","volume":"55","author":"K Das","year":"2012","unstructured":"Das K. Antivirals targeting influenza a virus. J Med Chem. 2012;55(14):6263\u201377.","journal-title":"J Med Chem"},{"issue":"5","key":"567_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nsmb.1779","volume":"17","author":"K Das","year":"2010","unstructured":"Das K, Aramini JM, Ma LC, Krug RM, Arnold E. Structures of influenza a proteins and insights into antiviral drug targets. Nat Struct Mol Biol. 2010;17(5):530\u20138.","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"567_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/nrd2175","volume":"5","author":"E De Clercq","year":"2006","unstructured":"De Clercq E. Antiviral agents active against influenza a viruses. Nat Rev Drug Discov. 2006;5(12):1015\u201325.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"567_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913\u201323.","journal-title":"N Engl J Med"},{"issue":"12","key":"567_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrd2400","volume":"6","author":"M von Itzstein","year":"2007","unstructured":"von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat Rev Drug Discov. 2007;6(12):967\u201374.","journal-title":"Nat Rev Drug Discov"},{"issue":"7178","key":"567_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature06528","volume":"451","author":"AL Stouffer","year":"2008","unstructured":"Stouffer AL, Acharya R, Salom D, Levine AS, Di Costanzo L, Soto CS, Tereshko V, Nanda V, Stayrook S, DeGrado WF. Structural basis for the function and inhibition of an influenza virus proton channel. Nature. 2008;451(7178):596\u20139.","journal-title":"Nature."},{"issue":"7178","key":"567_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06531","volume":"451","author":"JR Schnell","year":"2008","unstructured":"Schnell JR, Chou JJ. Structure and mechanism of the M2 proton channel of influenza a virus. Nature. 2008;451(7178):591\u20135.","journal-title":"Nature."},{"key":"567_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1741-7015-10-104","volume":"10","author":"S Barik","year":"2012","unstructured":"Barik S. New treatments for influenza. BMC Med. 2012;10:104.","journal-title":"BMC Med"},{"issue":"1","key":"567_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/jiq005","volume":"203","author":"TG Sheu","year":"2011","unstructured":"Sheu TG, Fry AM, Garten RJ, Deyde VM, Shwe T, Bullion L, Peebles PJ, Li Y, Klimov AI, Gubareva LV. Dual resistance to adamantanes and oseltamivir among seasonal influenza a(H1N1) viruses: 2008-2010. J Infect Dis. 2011;203(1):13\u20137.","journal-title":"J Infect Dis"},{"issue":"4","key":"567_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1517\/13543776.2013.765861","volume":"23","author":"S Chamni","year":"2013","unstructured":"Chamni S, De-Eknamkul W. Recent progress and challenges in the discovery of new neuraminidase inhibitors. Expert Opin Ther Pat. 2013;23(4):409\u201323.","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"567_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jac\/dky462","volume":"74","author":"K Fukao","year":"2019","unstructured":"Fukao K, Noshi T, Yamamoto A, Kitano M, Ando Y, Noda T, Baba K, Matsumoto K, Higuchi N, Ikeda M, Shishido T, Naito A. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza a virus infection. J Antimicrob Chemother. 2019;74(3):654\u201362.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"567_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/molecules21111513","volume":"21","author":"P Laborda","year":"2016","unstructured":"Laborda P, Wang SY, Voglmeir J. Influenza neuraminidase inhibitors: synthetic approaches, derivatives and biological activity. Molecules. 2016;21(11):1513\u201353.","journal-title":"Molecules."},{"issue":"13","key":"567_CR28","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","volume":"353","author":"A Moscona","year":"2005","unstructured":"Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med. 2005;353(13):1363\u201373.","journal-title":"N Engl J Med"},{"issue":"4","key":"567_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00003495-199958040-00016","volume":"58","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL. Zanamivir, a review of its use in influenza. Drugs. 1999;58(4):761\u201384.","journal-title":"Drugs."},{"issue":"1","key":"567_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00003495-200262010-00004","volume":"62","author":"SM Cheer","year":"2002","unstructured":"Cheer SM, Wagstaff AJ. Zanamivir, an update of its use in influenza. Drugs. 2002;62(1):71\u2013106.","journal-title":"Drugs."},{"issue":"12","key":"567_CR31","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1021\/jm980162u","volume":"41","author":"CU Kim","year":"1998","unstructured":"Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J Med Chem. 1998;41(12):2451\u201360.","journal-title":"J Med Chem"},{"issue":"2","key":"567_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003495-200161020-00011","volume":"61","author":"K McClellan","year":"2001","unstructured":"McClellan K, Perry CM. Oseltamivir, a review of its use in influenza. Drugs. 2001;61(2):263\u201383.","journal-title":"Drugs."},{"issue":"3","key":"567_CR33","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1128\/AAC.01311-09","volume":"54","author":"S Kubo","year":"2010","unstructured":"Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M. Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration. Antimicrob Agents Chemother. 2010;54(3):1256\u201364.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"567_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1517\/13543784.11.6.859","volume":"11","author":"DF Smee","year":"2002","unstructured":"Smee DF, Sidwell RW. Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza. Expert Opin Investig Drugs. 2002;11(6):859\u201369.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"567_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/cid\/cir010","volume":"52","author":"S Jain","year":"2011","unstructured":"Jain S, Fry AM. Peramivir: another tool for influenza treatment? Clin Infect Dis. 2011;52(6):707\u20139.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"567_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","volume":"36","author":"LMR Cass","year":"1999","unstructured":"Cass LMR, Efthymiopoulos C, Bye A. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet. 1999;36(Suppl 1):1\u201311.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"567_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1473-3099(09)70199-9","volume":"9","author":"J Burch","year":"2009","unstructured":"Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):537\u201345.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"567_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1586\/eri.11.112","volume":"9","author":"H Ikematsu","year":"2011","unstructured":"Ikematsu H, Kawai N. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Rev Anti-Infect Ther. 2011;9(10):851\u20137.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"23","key":"567_CR39","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMp0910479","volume":"361","author":"D Birnkrant","year":"2009","unstructured":"Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med. 2009;361(23):2204\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"567_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1086\/518936","volume":"196","author":"VM Deyde","year":"2007","unstructured":"Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI. Surveillance of resistance to adamantanes among influenza a(H3N2) and a(H1N1) viruses isolated worldwide. J Infect Dis. 2007;196(2):249\u201357.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"567_CR41","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/591851","volume":"48","author":"F Hayden","year":"2009","unstructured":"Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis. 2009;48(Suppl 1):S3\u2013S13.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"567_CR42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer A, Lackenby A, Hungnes O, Lina B, van-der Werf S, Schweiger B, Opp M, Paget J, van-de Kassteele J, Hay A, Zambon M. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u20132008 season. Emerg Infect Dis. 2009;15(4):552\u201360.","journal-title":"Emerg Infect Dis"},{"issue":"5983","key":"567_CR43","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"JD Bloom","year":"2010","unstructured":"Bloom JD, Gong LI, Baltimore D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science. 2010;328(5983):1272\u20135.","journal-title":"Science."},{"issue":"12","key":"567_CR44","doi-asserted-by":"publisher","first-page":"e1002431","DOI":"10.1371\/journal.ppat.1002431","volume":"7","author":"Y Abed","year":"2011","unstructured":"Abed Y, Pizzorno A, Bouhy X, Boivin G. Role of permissive neuraminidase mutations in influenza a\/Brisbane\/59\/2007-like (H1N1) viruses. PLoS Pathog. 2011;7(12):e1002431.","journal-title":"PLoS Pathog"},{"issue":"1","key":"567_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0969-2126(93)90005-2","volume":"1","author":"WP Burmeister","year":"1993","unstructured":"Burmeister WP, Henrissat B, Bosso C, Cusack S, Ruigrok RWH. Influenza-B virus neuraminidase can synthetize its own inhibitor. Structure. 1993;1(1):19\u201326.","journal-title":"Structure."},{"issue":"6428","key":"567_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M von Itzstein","year":"1993","unstructured":"von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363(6428):418\u201323.","journal-title":"Nature."},{"issue":"7107","key":"567_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature05114","volume":"443","author":"RJ Russell","year":"2006","unstructured":"Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature. 2006;443(7107):45\u20139.","journal-title":"Nature."},{"issue":"5","key":"567_CR48","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm00031a011","volume":"37","author":"NR Taylor","year":"1994","unstructured":"Taylor NR, von Itzstein M. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J Med Chem. 1994;37(5):616\u201324.","journal-title":"J Med Chem"},{"issue":"27","key":"567_CR49","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1021\/bi00193a002","volume":"33","author":"MN Janakiraman","year":"1994","unstructured":"Janakiraman MN, White CL, Laver WG, Air GM, Luo M. Structure of influenza virus neuraminidase B\/Lee\/40 complexed with sialic acid and a dehydro analog at 1.8-\u00c5 resolution: implications for the catalytic mechanism. Biochemistry. 1994;33(27):8172\u20139.","journal-title":"Biochemistry."},{"issue":"12","key":"567_CR50","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","volume":"46","author":"MZ Wang","year":"2002","unstructured":"Wang MZ, Tai CY, Mendel DB. Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother. 2002;46(12):3809\u201316.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7199","key":"567_CR51","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nature06956","volume":"453","author":"PJ Collins","year":"2008","unstructured":"Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature. 2008;453(7199):1258\u201362.","journal-title":"Nature."},{"issue":"1","key":"567_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","volume":"47","author":"JL McKimm-Breschkin","year":"2000","unstructured":"McKimm-Breschkin JL. Resistance of influenza viruses to neuraminidase inhibitors \u2013 a review. Antivir Res. 2000;47(1):1\u201317.","journal-title":"Antivir Res"},{"issue":"4","key":"567_CR53","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.bmcl.2004.12.024","volume":"15","author":"JR Proudfoot","year":"2005","unstructured":"Proudfoot JR. The evolution of synthetic oral drug properties. Bioorg Med Chem Lett. 2005;15(4):1087\u201390.","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"567_CR54","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2165\/11534730-000000000-00000","volume":"49","author":"N Widmer","year":"2010","unstructured":"Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Buclin T. Oseltamivir in seasonal, avian H5N1 and pandemic 2009 a\/H1N1 influenza. Clin Pharmacokinet. 2010;49(11):741\u201365.","journal-title":"Clin Pharmacokinet"},{"issue":"17","key":"567_CR55","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1016\/j.bmcl.2007.06.049","volume":"17","author":"ZY Liu","year":"2007","unstructured":"Liu ZY, Wang B, Zhao LX, Li YH, Shao HY, Yi H, You XF, Li ZR. Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir). Bioorg Med Chem Lett. 2007;17(17):4851\u20134.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"567_CR56","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1021\/mp200291x","volume":"8","author":"SV Gupta","year":"2011","unstructured":"Gupta SV, Gupta D, Sun J, Dahan A, Tsume Y, Hilfinger J, Lee KD, Amidon GL. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach. Mol Pharm. 2011;8(6):2358\u201367.","journal-title":"Mol Pharm"},{"issue":"4","key":"567_CR57","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1021\/mp100050d","volume":"7","author":"JM Miller","year":"2010","unstructured":"Miller JM, Dahan A, Gupta D, Varghese S, Amidon GL. Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. Mol Pharm. 2010;7(4):1223\u201334.","journal-title":"Mol Pharm"},{"issue":"1\u20133","key":"567_CR58","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0378-5173(86)90055-4","volume":"33","author":"PL Gould","year":"1986","unstructured":"Gould PL. Salt selection for basic drugs. Int J Pharm. 1986;33(1\u20133):201\u201317.","journal-title":"Int J Pharm"},{"issue":"1","key":"567_CR59","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00003088-200241010-00003","volume":"41","author":"M Cazzola","year":"2002","unstructured":"Cazzola M, Testi R, Matera MG. Clinical pharmacokinetics of salmeterol. Clin Pharmacokinet. 2002;41(1):19\u201330.","journal-title":"Clin Pharmacokinet"},{"issue":"16","key":"567_CR60","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1016\/j.bmc.2011.06.080","volume":"19","author":"KC Liu","year":"2011","unstructured":"Liu KC, Lee PS, Wang SY, Cheng YSE, Fang JM, Wong CH. Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir. Bioorg Med Chem. 2011;19(16):4796\u2013802.","journal-title":"Bioorg Med Chem"},{"key":"567_CR61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejmech.2018.05.030","volume":"154","author":"PH Hsu","year":"2018","unstructured":"Hsu PH, Chiu DC, Wu KL, Lee PS, Jan JT, Cheng YSE, Tsai KC, Cheng TJ, Fang JM. Acylguanidine derivatives of Zanamivir and Oseltamivir: potential orally available Prodrugs against influenza viruses. Eur J Med Chem. 2018;154:314\u201323.","journal-title":"Eur J Med Chem"},{"key":"567_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/ncomms1114","volume":"1","author":"S Rudrawar","year":"2010","unstructured":"Rudrawar S, Dyason JC, Rameix-Welti MA, Rose FJ, Kerry PS, Russell RJ, van der Werf S, Thomson RJ, Naffakh N, von Itzstein M. Novel sialic acid derivatives lock open the 150-loop of an influenza a virus group-1 sialidase. Nat Commun. 2010;1:113.","journal-title":"Nat Commun"},{"issue":"25","key":"567_CR63","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1021\/ja0723535","volume":"129","author":"RE Amaro","year":"2007","unstructured":"Amaro RE, Minh DDL, Cheng LS, Lindstrom WM Jr, Olson AJ, Lin JH, Li WW, McCammon JA. Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design. J Am Chem Soc. 2007;129(25):7764\u20135.","journal-title":"J Am Chem Soc"},{"issue":"24","key":"567_CR64","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1039\/c3ob40624e","volume":"11","author":"CH Lin","year":"2013","unstructured":"Lin CH, Chang TC, Das A, Fang MY, Hung HC, Hsu KC, Yang JM, von Itzstein M, Mong KK, Hsu TA, Lin CC. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities. Org Biomol Chem. 2013;11(24):3943\u20138.","journal-title":"Org Biomol Chem"},{"key":"567_CR65","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ejmech.2016.07.064","volume":"123","author":"A Das","year":"2016","unstructured":"Das A, Adak AK, Ponnapalli K, Lin CH, Hsu KC, Yang JM, Hsu TA, Lin CC. Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors. Eur J Med Chem. 2016;123:397\u2013406.","journal-title":"Eur J Med Chem"},{"issue":"10","key":"567_CR66","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.bmc.2017.03.052","volume":"25","author":"Z Li","year":"2017","unstructured":"Li Z, Meng Y, Xu S, Shen W, Meng Z, Wang Z, Ding G, Huang W, Xiao W, Xu J. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors. Bioorg Med Chem. 2017;25(10):2772\u201381.","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"567_CR67","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1021\/cr950066q","volume":"96","author":"GA Patani","year":"1996","unstructured":"Patani GA, LaVoie EJ. Bioisosterism: a rational approach in drug design. Chem Rev. 1996;96(8):3147\u201376.","journal-title":"Chem Rev"},{"issue":"8","key":"567_CR68","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1021\/jm1013693","volume":"54","author":"NA Meanwell","year":"2011","unstructured":"Meanwell NA. Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem. 2011;54(8):2529\u201391.","journal-title":"J Med Chem"},{"key":"567_CR69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-3002(60)91544-4","volume":"44","author":"JN Walop","year":"1960","unstructured":"Walop JN, Boschman TAC, Jacobs J. Affinity of N-acetylneuraminic acid for influenza virus neuraminidase. Biochim Biophys Acta. 1960;44:185\u20136.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"567_CR70","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/anie.198002081","volume":"19","author":"H Friebolin","year":"1980","unstructured":"Friebolin H, Supp M, Brossmer R, Keilich G, Ziegler D. 1H-NMR investigations on the mutarotation of N-acetyl-D-neuraminic acid. Angew Chem Int Ed Engl. 1980;19(3):208\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"567_CR71","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/hlca.19900730523","volume":"73","author":"K Wallimann","year":"1990","unstructured":"Wallimann K, Vasella A. Phosphonic-acid analogues of the N-acetyl-2-deoxyneuraminic acids: synthesis and inhibition of Vibrio cholerae sialidase. Helv Chim Acta. 1990;73(5):1359\u201372.","journal-title":"Helv Chim Acta."},{"issue":"11","key":"567_CR72","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1021\/jo961891p","volume":"62","author":"TH Chan","year":"1997","unstructured":"Chan TH, Xin YC, von Itzstein M. Synthesis of phosphonic acid analogues of sialic acids (Neu5Ac and KDN) as potential sialidase inhibitors. J Org Chem. 1997;62(11):3500\u20134.","journal-title":"J Org Chem"},{"issue":"1","key":"567_CR73","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1038\/s41598-017-07836-y","volume":"7","author":"CJ Vavricka","year":"2017","unstructured":"Vavricka CJ, Muto C, Hasunuma T, Kimura Y, Araki M, Wu Y, Gao GF, Ohrui H, Izumi M, Kiyota H. Synthesis of sulfo-sialic acid analogues: potent neuraminidase inhibitors in regards to anomeric functionality. Sci Rep. 2017;7(1):8239.","journal-title":"Sci Rep"},{"issue":"25","key":"567_CR74","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1039\/C7OB00947J","volume":"15","author":"\u00c1 Hadh\u00e1zi","year":"2017","unstructured":"Hadh\u00e1zi \u00c1, Pascolutti M, Bailly B, Dyason JC, Borb\u00e1s A, Thomson RJ, von Itzstein M. A sialosyl sulfonate as a potent inhibitor of influenza virus replication. Org Biomol Chem. 2017;15(25):5249\u201353.","journal-title":"Org Biomol Chem."},{"issue":"8","key":"567_CR75","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/cmdc.201800092","volume":"13","author":"\u00c1 Hadh\u00e1zi","year":"2018","unstructured":"Hadh\u00e1zi \u00c1, Li L, Bailly B, Maggioni A, Martin G, Dirr L, Dyason JC, Thomson RJ, Gao GF, Borb\u00e1s A, Ve T, Pascolutti M, von Itzstein M. A sulfonozanamivir analogue has potent anti-influenza virus activity. ChemMedChem. 2018;13(8):785\u20139.","journal-title":"ChemMedChem."},{"issue":"3","key":"567_CR76","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/cmdc.201200585","volume":"8","author":"C Ballatore","year":"2013","unstructured":"Ballatore C, Huryn DM, Smith AB 3rd. Carboxylic acid (bio) isosteres in drug design. ChemMedChem. 2013;8(3):385\u201395.","journal-title":"ChemMedChem."},{"issue":"1","key":"567_CR77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/cr040603j","volume":"105","author":"KA Schug","year":"2005","unstructured":"Schug KA, Lindner W. Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine\/guanidinium interactions with phosph[on]ate and sulf[on]ate residues. Chem Rev. 2005;105(1):67\u2013114.","journal-title":"Chem Rev"},{"issue":"18","key":"567_CR78","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1093\/nar\/gkn577","volume":"36","author":"VA Klenchin","year":"2008","unstructured":"Klenchin VA, Czyz A, Goryshin IY, Gradman R, Lovell S, Rayment I, Reznikoff WS. Phosphate coordination and movement of DNA in the Tn5 synaptic complex: role of the (R)YREK motif. Nucleic Acids Res. 2008;36(18):5855\u201362.","journal-title":"Nucleic Acids Res"},{"issue":"44","key":"567_CR79","doi-asserted-by":"publisher","first-page":"17959","DOI":"10.1021\/ja207892q","volume":"133","author":"JJ Shie","year":"2011","unstructured":"Shie JJ, Fang JM, Lai PT, Wen WH, Wang SY, Cheng YSE, Tsai KC, Yang AS, Wong CH. A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity. J Am Chem Soc. 2011;133(44):17959\u201365.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"567_CR80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hlca.19910740223","volume":"74","author":"A Vasella","year":"1991","unstructured":"Vasella A, Wyler R. Synthesis of a phosphonic acid analogue of N-acetyl-2,3-didehydro-2-deoxyneuraminic acid, an inhibitor of Vibrio cholerae sialidase. Helv Chim Acta. 1991;74(2):451\u201363.","journal-title":"Helv Chim Acta"},{"issue":"2","key":"567_CR81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0008-6215(94)84065-2","volume":"259","author":"M von Itzstein","year":"1994","unstructured":"von Itzstein M, Wu WY, Jin B. The synthesis of 2,3-dehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor. Carbohydr Res. 1994;259(2):301\u20135.","journal-title":"Carbohydr Res"},{"issue":"17","key":"567_CR82","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1021\/acs.orglett.6b02131","volume":"18","author":"LZ Lin","year":"2016","unstructured":"Lin LZ, Fang JM. Total synthesis of anti-influenza agents zanamivir and zanaphosphor via asymmetric aza-Henry reaction. Org Lett. 2016;18(17):4400\u20133.","journal-title":"Org Lett"},{"issue":"39","key":"567_CR83","doi-asserted-by":"publisher","first-page":"11892","DOI":"10.1021\/ja073992i","volume":"129","author":"JJ Shie","year":"2007","unstructured":"Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YSE, Yang AS, Hsiao SC, Su CY, Wong CH. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity. J Am Chem Soc. 2007;129(39):11892\u20133.","journal-title":"J Am Chem Soc"},{"issue":"44","key":"567_CR84","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1039\/c3ob41622d","volume":"11","author":"CA Chen","year":"2013","unstructured":"Chen CA, Fang JM. Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine. Org Biomol Chem. 2013;11(44):7687\u201399.","journal-title":"Org Biomol Chem."},{"issue":"2","key":"567_CR85","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tet.2014.11.062","volume":"71","author":"YW Lo","year":"2015","unstructured":"Lo YW, Fang JM. A short synthetic pathway via three-component coupling reaction to tamiphosphor possessing anti-influenza activity. Tetrahedron. 2015;71(2):266\u201370.","journal-title":"Tetrahedron."},{"issue":"31","key":"567_CR86","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1002\/anie.200801959","volume":"47","author":"JJ Shie","year":"2008","unstructured":"Shie JJ, Fang JM, Wong CH. A concise and flexible synthesis of the potent anti-influenza agents-tamiflu and tamiphosphor. Angew Chem Int Ed. 2008;47(31):5788\u201391.","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"567_CR87","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/cmdc.200800379","volume":"4","author":"B Carbain","year":"2009","unstructured":"Carbain B, Collins PJ, Callum L, Martin SR, Hay AJ, McCauley J, Streicher H. Efficient synthesis of highly active phospha-isosteres of the influenza neuraminidase inhibitor oseltamivir. ChemMedChem. 2009;4(3):335\u20137.","journal-title":"ChemMedChem."},{"issue":"4","key":"567_CR88","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1055\/s-0031-1290356","volume":"23","author":"DS Gunasekera","year":"2012","unstructured":"Gunasekera DS. Formal synthesis of tamiflu: conversion of tamiflu into tamiphosphor. Synlett. 2012;23(4):573\u20136.","journal-title":"Synlett."},{"issue":"18","key":"567_CR89","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.2165\/00003495-200464180-00003","volume":"64","author":"AC Schmidt","year":"2004","unstructured":"Schmidt AC. Antiviral therapy for influenza : a clinical and economic comparative review. Drugs. 2004;64(18):2031\u201346.","journal-title":"Drugs."},{"issue":"4","key":"567_CR90","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1021\/pr050077s","volume":"4","author":"AS Woods","year":"2005","unstructured":"Woods AS, Ferr\u00e9 S. Amazing stability of the arginine\u2212phosphate electrostatic interaction. J Proteome Res. 2005;4(4):1397\u2013402.","journal-title":"J Proteome Res"},{"issue":"4","key":"567_CR91","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.bbamem.2007.12.003","volume":"1778","author":"A Pantos","year":"2008","unstructured":"Pantos A, Tsogas I, Paleos CM. Guanidinium group: a versatile moiety inducing transport and multicompartmentalization in complementary membranes. Biochim Biophys Acta. 2008;1778(4):811\u201323.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"567_CR92","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1039\/c2md20034a","volume":"3","author":"M Stanley","year":"2012","unstructured":"Stanley M, Cattle N, McCauley J, Rashid M, Field AR, Carbain B, Streicher H. 'TamiGold': phospha-oseltamivir-stabilised gold nanoparticles as the basis for influenza therapeutics and diagnostics targeting the neuraminidase (instead of the hemagglutinin). Med Chem Commun. 2012;3(11):1373\u20136.","journal-title":"Med Chem Commun"},{"issue":"20","key":"567_CR93","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1021\/jm3008486","volume":"55","author":"TJ Cheng","year":"2012","unstructured":"Cheng TJ, Weinheimer S, Tarbet EB, Jan JT, Cheng YS, Shie JJ, Chen CL, Chen CA, Hsieh WC, Huang PW, Lin WH, Wang SY, Fang JM, Hu OY, Wong CH. Development of oseltamivir phosphonate congeners as anti-influenza agents. J Med Chem. 2012;55(20):8657\u201370.","journal-title":"J Med Chem"},{"issue":"11","key":"567_CR94","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1021\/acs.jmedchem.6b00029","volume":"59","author":"PC Wang","year":"2016","unstructured":"Wang PC, Fang JM, Tsai KC, Wang SY, Huang WI, Tseng YC, Cheng YSE, Cheng TJR, Wong CH. Peramivir phosphonate derivatives as influenza neuraminidase inhibitors. J Med Chem. 2016;59(11):5297\u2013310.","journal-title":"J Med Chem"},{"issue":"10","key":"567_CR95","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1021\/ci900277r","volume":"49","author":"T Udommaneethanakit","year":"2009","unstructured":"Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M. Dynamic behavior of avian influenza a virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues. J Chem Inf Model. 2009;49(10):2323\u201332.","journal-title":"J Chem Inf Model"},{"issue":"11","key":"567_CR96","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1021\/jm010528u","volume":"45","author":"BJ Smith","year":"2002","unstructured":"Smith BJ, McKimm-Breshkin JL, McDonald M, Fernley RT, Varghese JN, Colman PM. Structural studies of the resistance of influenza virus neuraminidase to inhibitors. J Med Chem. 2002;45(11):2207\u201312.","journal-title":"J Med Chem"},{"issue":"18","key":"567_CR97","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","volume":"69","author":"AC Hurt","year":"2009","unstructured":"Hurt AC, Holien JK, Parker MW, Barr IG. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs. 2009;69(18):2523\u201331.","journal-title":"Drugs."},{"key":"567_CR98","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.ejmech.2018.12.027","volume":"163","author":"BT Hong","year":"2019","unstructured":"Hong BT, Cheng YSE, Cheng TJ, Fang JM. Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: synthesis and anti-influenza activity. Eur J Med Chem. 2019;163:710\u201321.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"567_CR99","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/0960-894X(96)00318-6","volume":"6","author":"SL Sollis","year":"1996","unstructured":"Sollis SL, Smith PW, Howes PD, Cherry PC, Bethell RC. Novel inhibitors of influenza sialidase related to GG167. Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase. Bioorg Med Chem Lett. 1996;6(15):1805\u20138.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"567_CR100","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1021\/jm970374b","volume":"41","author":"PW Smith","year":"1998","unstructured":"Smith PW, Sollis SL, Howes PD, Cherry PC, Starkey ID, Cobley KN, et al. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides. J Med Chem. 1998;41(6):787\u201397.","journal-title":"J Med Chem"},{"issue":"24","key":"567_CR101","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1016\/S0960-894X(96)00542-2","volume":"6","author":"PW Smith","year":"1996","unstructured":"Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell RC. Novel inhibitors of influenza sialidases related to GG167 structure\u2013activity, crystallographic and molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides. Bioorg Med Chem Lett. 1996;6(24):2931\u20136.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"567_CR102","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/jm9703754","volume":"41","author":"NR Taylor","year":"1998","unstructured":"Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types a and B. J Med Chem. 1998;41(6):798\u2013807.","journal-title":"J Med Chem"},{"issue":"6","key":"567_CR103","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/pro.5560040606","volume":"4","author":"JN Varghese","year":"1995","unstructured":"Varghese JN, Epa VC, Colman PM. Three-dimensional structure of the complex of 4-guanidino-NeuSAc2en and influenza virus neuraminidase. Protein Sci. 1995;4(6):1081\u20137.","journal-title":"Protein Sci"},{"issue":"1","key":"567_CR104","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/AAC.00333-08","volume":"53","author":"M Yamashita","year":"2009","unstructured":"Yamashita M, Tomozawa T, Kakuta M, Tokumitsu A, Nau H, Kubo S. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother. 2009;53(1):186\u201392.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"567_CR105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3851\/IMP1688","volume":"21","author":"M Yamashita","year":"2010","unstructured":"Yamashita M. Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza. Antivir Chem Chemother. 2010;21(2):71\u201384.","journal-title":"Antivir Chem Chemother"},{"issue":"11","key":"567_CR106","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1177\/0091270009356297","volume":"50","author":"H Ishizuka","year":"2010","unstructured":"Ishizuka H, Yoshiba S, Okabe H, Yoshihara K. Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers. J Clin Pharmacol. 2010;50(11):1319\u201329.","journal-title":"J Clin Pharmacol"},{"issue":"3\u20134","key":"567_CR107","first-page":"563","volume":"34","author":"DM Andrews","year":"1999","unstructured":"Andrews DM, Cherry PC, Humber DC, Jones PS, Keeling SP, Martin PF, Shaw CD, Swanson S. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (zanamivir) modified in the glycerol side-chain. Eur J Med Chem. 1999;34(3\u20134):563\u201374.","journal-title":"Eur J Med Chem"},{"issue":"11","key":"567_CR108","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2189","volume":"5","author":"S Frantz","year":"2006","unstructured":"Frantz S. The trouble with making combination drugs. Nat Rev Drug Discov. 2006;5(11):881\u20132.","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"567_CR109","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"R Morphy","year":"2005","unstructured":"Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48(21):6523\u201343.","journal-title":"J Med Chem"},{"issue":"9\u201310","key":"567_CR110","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","volume":"18","author":"JL Medina-Franco","year":"2013","unstructured":"Medina-Franco JL, Giulianotti MA, Welmaker GS, Houghten RA. Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today. 2013;18(9\u201310):495\u2013501.","journal-title":"Drug Discov Today"},{"issue":"1","key":"567_CR111","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1039\/cs9952400019","volume":"24","author":"R Bonnett","year":"1995","unstructured":"Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Rev Soc. 1995;24(1):19\u201333.","journal-title":"Chem Rev Soc"},{"issue":"2","key":"567_CR112","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jpp.328","volume":"5","author":"IJ Macdonal","year":"2001","unstructured":"Macdonal IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines. 2001;5(2):105\u201329.","journal-title":"J Porphyrins Phthalocyanines"},{"issue":"4","key":"567_CR113","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","volume":"1","author":"AP Castano","year":"2004","unstructured":"Castano AP, Demidova TN, Hambline MR. Mechanism in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther. 2004;1(4):279\u201393.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"7","key":"567_CR114","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nbt0794-703","volume":"12","author":"F Berthiaume","year":"1994","unstructured":"Berthiaume F, Reiken SR, Toner M, Tompkins RG, Yarmush ML. Antibody-targeted photolysis of bacteria in vivo. Nat Biotechnology. 1994;12(7):703\u20136.","journal-title":"Nat Biotechnology"},{"issue":"5","key":"567_CR115","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1039\/b311903n","volume":"3","author":"M Wainwright","year":"2004","unstructured":"Wainwright M. Photoinactivation of viruses. Photochem Photobiol Sci. 2004;3(5):406\u201311.","journal-title":"Photochem Photobiol Sci."},{"issue":"5","key":"567_CR116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1039\/b311900a","volume":"3","author":"MR Hamblin","year":"2004","unstructured":"Hamblin MR, Hasan T. Photodynamic therapy a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3(5):436\u201350.","journal-title":"Photochem Photobiol Sci"},{"issue":"15","key":"567_CR117","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1021\/jm900515g","volume":"52","author":"WH Wen","year":"2009","unstructured":"Wen WH, Lin M, Su CY, Wang SY, Cheng YS, Fang JM, Wong CH. Synergistic effect of zanamivir\u2013porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus. J Med Chem. 2009;52(15):4903\u201310.","journal-title":"J Med Chem"},{"issue":"8","key":"567_CR118","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1021\/ar00056a001","volume":"28","author":"YC Lee","year":"1995","unstructured":"Lee YC, Lee RT. Carbohydrate\u2013protein interactions: basis of glycobiology. Acc Chem Res. 1995;28(8):321\u20137.","journal-title":"Acc Chem Res"},{"issue":"21","key":"567_CR119","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1021\/jm00021a007","volume":"38","author":"M Mammen","year":"1995","unstructured":"Mammen M, Dahmann G, Whitesides GM. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. J Med Chem. 1995;38(21):4179\u201390.","journal-title":"J Med Chem"},{"issue":"20","key":"567_CR120","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","volume":"37","author":"M Mammen","year":"1998","unstructured":"Mammen M, Choi SK, Whitesides GM. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed Engl. 1998;37(20):2754\u201394.","journal-title":"Angew Chem Int Ed Engl."},{"issue":"2","key":"567_CR121","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1021\/cr000418f","volume":"102","author":"JJ Lundquist","year":"2002","unstructured":"Lundquist JJ, Toone EJ. The cluster glycoside effect. Chem Rev. 2002;102(2):555\u201378.","journal-title":"Chem Rev"},{"issue":"12","key":"567_CR122","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1128\/AAC.48.12.4542-4549.2004","volume":"48","author":"SJ Macdonald","year":"2004","unstructured":"Macdonald SJ, Watson KG, Cameron R, Chalmers DK, Demaine DA, Fenton RJ, et al. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen. Antimicrob Agents Chemother. 2004;48(12):4542\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"567_CR123","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.bmcl.2003.09.102","volume":"14","author":"KG Watson","year":"2004","unstructured":"Watson KG, Cameron R, Fenton RJ, Gower D, Hamilton S, Jin B, et al. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase. Bioorg Med Chem Lett. 2004;14(6):1589\u201392.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"567_CR124","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1021\/jm040891b","volume":"48","author":"SJ Macdonald","year":"2005","unstructured":"Macdonald SJ, Cameron R, Demaine DA, Fenton RJ, Foster G, Gower D, et al. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. J Med Chem. 2005;48(8):2964\u201371.","journal-title":"J Med Chem"},{"key":"567_CR125","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1039\/C2MD20300F","volume":"4","author":"BH Fraser","year":"2013","unstructured":"Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucke SP, et al. Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza a and B. Med Chem Commun. 2013;4:383\u20136.","journal-title":"Med Chem Commun"},{"issue":"15","key":"567_CR126","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0960-894X(02)00328-1","volume":"12","author":"T Honda","year":"2002","unstructured":"Honda T, Masuda T, Yoshida S, Arai M, Kobayashi Y, Yamashita M. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives. Bioorg Med Chem Lett. 2002;12(15):1921\u20134.","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"567_CR127","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/jps.22338","volume":"100","author":"AK Weight","year":"2011","unstructured":"Weight AK, Haldar J, \u00c1lvarez de Cienfuegos L, Gubareva LV, Tumpey TM, Chen J, Klibanov AM. Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus. J Pharm Sci. 2011;100(3):831\u20135.","journal-title":"J Pharm Sci"},{"issue":"50","key":"567_CR128","doi-asserted-by":"publisher","first-page":"20385","DOI":"10.1073\/pnas.1219155109","volume":"109","author":"CM Lee","year":"2012","unstructured":"Lee CM, Weight AK, Haldar J, Wang L, Klibanov AM, Chen J. Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection. Proc Natl Acad Sci U S A. 2012;109(50):20385\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"567_CR129","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11095-009-0013-1","volume":"27","author":"J Haldar","year":"2010","unstructured":"Haldar J. \u00c1lvarez de Cienfuegos L, Tumpey TM, Gubareva LV, Chen J, Klibanov AM. Bifunctional polymeric inhibitors of human influenza a viruses. Pharm Res. 2010;27(2):259\u201363.","journal-title":"Pharm Res"},{"issue":"19","key":"567_CR130","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.1021\/jm3009844","volume":"55","author":"KC Liu","year":"2012","unstructured":"Liu KC, Fang JM, Jan JT, Cheng TJ, Wang SY, Yang ST, Cheng YSE, Wong CH. Enhanced anti-influenza agents conjugated with anti-inflammatory activity. J Med Chem. 2012;55(19):8493\u2013501.","journal-title":"J Med Chem"},{"issue":"30","key":"567_CR131","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1073\/pnas.0705289104","volume":"104","author":"R Salomon","year":"2007","unstructured":"Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A. 2007;104(30):12479\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"567_CR132","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1750-2659.2009.00090.x","volume":"3","author":"DS Fedson","year":"2009","unstructured":"Fedson DS. Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Respir Viruses. 2009;3(4):129\u201342.","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"567_CR133","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ppul.10320","volume":"36","author":"M Ottolini","year":"2003","unstructured":"Ottolini M, Blanco J, Porter D, Peterson L, Curtis S, Prince G. Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol. 2003;36(4):290\u20134.","journal-title":"Pediatr Pulmonol"},{"issue":"23","key":"567_CR134","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1073\/pnas.0711942105","volume":"105","author":"BJ Zheng","year":"2008","unstructured":"Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, Chen HL, Wong SS, Lau SK, Woo PC, Chan KH, Jin DY, Yuen KY. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza a\/H5N1 virus. Proc Natl Acad Sci U S A. 2008;105(23):8091\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"567_CR135","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1021\/jm0002679","volume":"43","author":"YS Babu","year":"2000","unstructured":"Babu YS, Chand P, Bantia S, Kotian P, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Elliott AJ, Parker CD, Ananth SL, Horn LL, Laver GW, Montgomery JA. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem. 2000;43(19):3482\u20136.","journal-title":"J Med Chem"},{"key":"567_CR136","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3389\/fmicb.2016.00450","volume":"7","author":"MM Alame","year":"2016","unstructured":"Alame MM, Massaad E, Zaraket H. Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front Microbiol. 2016;7:450.","journal-title":"Front Microbiol"},{"key":"567_CR137","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejmech.2017.12.072","volume":"145","author":"PC Wang","year":"2018","unstructured":"Wang PC, Chiu DC, Jan JT, Huang WI, Tseng YC, Li TT, Cheng TJ, Tsai KC, Fang JM. Peramivir conjugates as orally available agents against influenza H275Y mutant. Eur J Med Chem. 2018;145:224\u201334.","journal-title":"Eur J Med Chem"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0567-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-019-0567-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0567-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:16:10Z","timestamp":1603307770000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-019-0567-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/s12929-019-0567-0","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}